A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

NCT00000919 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

900

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Lamivudine/Zidovudine
DRUG: Ritonavir
DRUG: Hydroxyurea
DRUG: Abacavir sulfate
DRUG: Amprenavir
DRUG: Nelfinavir mesylate
DRUG: Efavirenz
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)